Brain delivery research in public-private partnerships: The IMI-JU COMPACT consortium as an example

The Blood-Brain Barrier (BBB) represents a major hurdle in the development of treatments for CNS disorders due to the fact that it very effectively keeps drugs, especially biological macromolecules, out of the brain. Concomitantly with the increasing importance of biologics research on the BBB and,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuropharmacology 2017-07, Vol.120, p.8-10
Hauptverfasser:	Meyer, Axel H., Untucht, Christopher, Terstappen, Georg C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Biomedical Research Blood-Brain Barrier - drug effects Blood-Brain Barrier - physiology Brain - drug effects Brain - physiology Brain delivery Humans IMI-JU Macromolecular Substances - pharmacology Macromolecular Substances - therapeutic use Public-private partnership Public-Private Sector Partnerships
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!